Etchin, J., Sanda, T., Mansour, M. R., Kentsis, A., Montero, J., Le, B. T., . . . Look, A. T. (2013). KPT-330 inhibitor of CRM1 (XPO1)-mediated nuclear export has selective anti-leukaemic activity in preclinical models of T-ALL and AML.
Citação norma ChicagoEtchin, Julia, et al. KPT-330 Inhibitor of CRM1 (XPO1)-mediated Nuclear Export Has Selective Anti-leukaemic Activity in Preclinical Models of T-ALL and AML. 2013.
Citação norma MLAEtchin, Julia, et al. KPT-330 Inhibitor of CRM1 (XPO1)-mediated Nuclear Export Has Selective Anti-leukaemic Activity in Preclinical Models of T-ALL and AML. 2013.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.